A receptor on bone cells called OSCAR grabs onto collagen and helps turn precursor cells into bone-eating cells by boosting a key signal (NFATc1) that tells them to break down bone.
Scientific Claim
Osteoclast-associated receptor (OSCAR) binds collagen I–III and, via FcRγ-ITAM signaling, enhances osteoclast differentiation and bone resorption by amplifying RANKL-induced NFATc1 activation.
Original Statement
“Human osteoclast-associated receptor (OSCAR) is another collagen receptor that belongs to the immunoglobulin (Ig) superfamily... OSCAR is expressed in a wide range of myeloid cells and is specifically involved in osteoclast growth induction for bone resorption... Collagen binding to OSCAR leads to conscription of immunoreceptor tyrosine-based activation motifs (ITAM) containing FcRγ chains. This process further activates the downstream effect of calcium signaling, which is essentially important for the activation of an osteoclastogenic transcription factor such as the nuclear factor of activated T-cells (NFAT) c1.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The review summarizes prior findings but does not provide original data to prove OSCAR directly causes osteoclast differentiation. 'Enhances' and 'amplifying' imply causal control beyond the evidence level.
More Accurate Statement
“Osteoclast-associated receptor (OSCAR) is associated with binding collagen I–III and is correlated with enhanced osteoclast differentiation and bone resorption through FcRγ-ITAM signaling and amplification of RANKL-induced NFATc1 activation based on prior experimental studies.”
Evidence from Studies
Supporting (0)
Contradicting (1)
This study talks generally about how collagen interacts with cells but doesn't mention the specific receptor (OSCAR) or bone-breaking cells (osteoclasts) in the claim, so it doesn't help prove or disprove it.